articleCancer CellFeb 20, 2025Closed access

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models

PPPatrizia PorazziSNSiena NasonZYZiqi YangACAlberto CarturanGGGuido Ghilardi

Hospital of the University of Pennsylvania · Parker Institute for Cancer Immunotherapy · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

47
total citations
FWCI
36.91
Percentile
100%
References
88
Citations per year

Authors

30

Topics & keywords

Topics
Keywords
  • Cancer immunotherapy
  • Adoptive immunotherapy
  • Immunotherapy
  • EZH2
  • Cancer research
  • Adoptive cell transfer
  • Cancer
  • Immunology
No related works found for this paper.

Funding